Experimental Hematology
Volume 36, Issue 5 , Pages 545-558.e1 , May 2008

Tumor necrosis factor-α and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation

  • Luis Fernandez

      Affiliations

    • Center of Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., USA
  • ,
  • Sonia Rodriguez

      Affiliations

    • Hermann B Wells Center, Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Ind., USA
    • Drs. Rodriguez and Huang contributed equally to the work.
  • ,
  • Hui Huang

      Affiliations

    • Center of Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., USA
    • Drs. Rodriguez and Huang contributed equally to the work.
  • ,
  • Angelo Chora

      Affiliations

    • Institute of Molecular Medicine, University of Lisbon, Lisbon, Portugal
  • ,
  • Jacquenilson Fernandes

      Affiliations

    • Center of Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., USA
  • ,
  • Christin Mumaw

      Affiliations

    • Hermann B Wells Center, Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Ind., USA
  • ,
  • Eugenia Cruz

      Affiliations

    • Institute of Molecular and Cellular Biology, Porto, Portugal
  • ,
  • Karen Pollok

      Affiliations

    • Hermann B Wells Center, Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Ind., USA
  • ,
  • Filipa Cristina

      Affiliations

    • Institute of Molecular Medicine, University of Lisbon, Lisbon, Portugal
  • ,
  • Joanne E. Price

      Affiliations

    • Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Conn., USA
  • ,
  • Michael J. Ferkowicz

      Affiliations

    • Hermann B Wells Center, Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Ind., USA
  • ,
  • David T. Scadden

      Affiliations

    • Center of Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., USA
  • ,
  • Matthias Clauss

      Affiliations

    • Department of Cellular and Integrative Physiology and Indiana Center for Vascular Biology and Medicine, Indiana University School of Medicine, Indianapolis, Ind., USA
  • ,
  • Angelo A. Cardoso

      Affiliations

    • Department of Medicine and Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Ind., USA
  • ,
  • Nadia Carlesso

      Affiliations

    • Center of Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., USA
    • Hermann B Wells Center, Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Ind., USA
    • Corresponding Author InformationOffprint requests to: Nadia Carlesso, M.D., Ph.D., Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, 1044 W. Walnut, Building R4, Room 421, Indianapolis, IN 46202

Received 28 November 2007 ,Accepted 24 December 2007.

References 

  1. Suda T, Arai F, Hirao A. Hematopoietic stem cells and their niche. Trends Immunol. 2005;26:426–433
  2. Rafii S, Shapiro F, Pettengell R, et al. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood. 1995;86:3353–3363
  3. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998;91:3527–3561
  4. Sieff CA, Tsai S, Faller DV. Interleukin 1 induces cultured human endothelial cell production of granulocyte-macrophage colony-stimulating factor. J Clin Invest. 1987;79:48–51
  5. Warner SJ, Auger KR, Libby P. Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. J Exp Med. 1987;165:1316–1331
  6. Broudy VC, Kaushansky K, Segal GM, Harlan JM, Adamson JW. Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A. 1986;83:7467–7471
  7. Zambidis ET, Oberlin E, Tavian M, Peault B. Blood-forming endothelium in human ontogeny: lessons from in utero development and embryonic stem cell culture. Trends Cardiovasc Med. 2006;16:95–101
  8. Tavian M, Coulombel L, Luton D, Clemente HS, Dieterlen-Lievre F, Peault B. Aorta-associated CD34+ hematopoietic cells in the early human embryo. Blood. 1996;87:67–72
  9. Rafii S, Mohle R, Shapiro F, Frey BM, Moore MA. Regulation of hematopoiesis by microvascular endothelium. Leuk Lymphoma. 1997;27:375–386
  10. Avecilla ST, Hattori K, Heissig B, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med. 2004;10:64–71
  11. Mohle R, Moore MA, Nachman RL, Rafii S. Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line. Blood. 1997;89:72–80
  12. Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005;121:11091121
  13. Moore KA, Lemischka IR. Stem cells and their niches. Science. 2006;311:1880–1885
  14. Sipkins DA, Wei X, Wu JW, et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature. 2005;435:969–973
  15. Li W, Johnson SA, Shelley WC, Yoder MC. Hematopoietic stem cell repopulating ability can be maintained in vitro by some primary endothelial cells. Exp Hematol. 2004;32:1226–1237
  16. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284:770–776
  17. Milner LA, Bigas A. Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood. 1999;93:2431–2448
  18. Han W, Ye Q, Moore MA. A soluble form of human Delta-like-1 inhibits differentiation of hematopoietic progenitor cells. Blood. 2000;95:1616–1625
  19. Karanu FN, Murdoch B, Miyabayashi T, et al. Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood. 2001;97:1960–1967
  20. Varnum-Finney B, Purton LE, Yu M, et al. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood. 1998;91:4084–4091
  21. Carlesso N, Aster JC, Sklar J, Scadden DT. Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood. 1999;93:838–848
  22. Sarmento LM, Huang H, Limon A, et al. Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27Kip1 degradation. J Exp Med. 2005;202:157–168
  23. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003;425:836–841
  24. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425:841–846
  25. Almeida-Porada G, Ascensao JL. Isolation, characterization, and biologic features of bone marrow endothelial cells. J Lab Clin Med. 1996;128:399–407
  26. de Wynter E, Allen T, Coutinho L, Flavell D, Flavell SU, Dexter TM. Localisation of granulocyte macrophage colony-stimulating factor in human long-term bone marrow cultures. Biological and immunocytochemical characterisation. J Cell Sci. 1993;106(Pt 3):761–769
  27. Garces C, Ruiz-Hidalgo MJ, Font de Mora J, et al. Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J Biol Chem. 1997;272:29729–29734
  28. Zlobin A, Jang M, Miele L. Toward the rational design of cell fate modifiers: notch signaling as a target for novel biopharmaceuticals. Curr Pharm Biotechnol. 2000;1:83–106
  29. Rajashekhar G, Willuweit A, Patterson CE, et al. Continuous endothelial cell activation increases angiogenesis: evidence for the direct role of endothelium linking angiogenesis and inflammation. J Vasc Res. 2006;43:193–204
  30. Willuweit A, Sass G, Schoneberg A, Eisel U, Tiegs G, Clauss M. Chronic inflammation and protection from acute hepatitis in transgenic mice expressing TNF in endothelial cells. J Immunol. 2001;167:3944–3952
  31. Luo B, Aster JC, Hasserjian RP, Kuo F, Sklar J. Isolation and functional analysis of a cDNA for human Jagged2, a gene encoding a ligand for the Notch1 receptor. Mol Cell Biol. 1997;17:6057–6067
  32. Hasserjian RP, Aster JC, Davi F, Weinberg DS, Sklar J. Modulated expression of notch1 during thymocyte development. Blood. 1996;88:970–976
  33. Classon M, Salama S, Gorka C, Mulloy R, Braun P, Harlow E. Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control. Proc Natl Acad Sci U S A. 2000;97:10820–10825
  34. Costa LF, Balcells M, Edelman ER, Nadler LM, Cardoso AA. Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-kappaB. Blood. 2006;107:285–292
  35. Veiga JP, Costa LF, Sallan SE, Nadler LM, Cardoso AA. Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival. Exp Hematol. 2006;34:610–621
  36. Berezovska O, Jack C, McLean P, et al. Aspartate mutations in presenilin and gamma-secretase inhibitors both impair notch1 proteolysis and nuclear translocation with relative preservation of notch1 signaling. J Neurochem. 2000;75:583–593
  37. Conboy IM, Conboy MJ, Smythe GM, Rando TA. Notch-mediated restoration of regenerative potential to aged muscle. Science. 2003;302:1575–1577
  38. Shimizu K, Chiba S, Saito T, et al. Integrity of intracellular domain of Notch ligand is indispensable for cleavage required for release of the Notch2 intracellular domain. EMBO J. 2002;21:294–302
  39. Sun H, Li L, Vercherat C, et al. Stra13 regulates satellite cell activation by antagonizing Notch signaling. J Cell Biol. 2007;177:647–657
  40. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 2004;6:R605–R615
  41. Motoike T, Loughna S, Perens E, et al. Universal GFP reporter for the study of vascular development. Genesis. 2000;28:75–81
  42. Rietschel ET, Kirikae T, Schade FU, et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994;8:217–225
  43. Pissarra L, Henrique D, Duarte A. Expression of hes6, a new member of the Hairy/Enhancer-of-split family, in mouse development. Mech Dev. 2000;95:275–278
  44. Varnum-Finney B, Brashem-Stein C, Bernstein ID. Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. Blood. 2003;101:1784–1789
  45. Suzuki T, Yokoyama Y, Kumano K, et al. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein. Stem Cells. 2006;24:2456–2465
  46. Dallas MH, Varnum-Finney B, Delaney C, Kato K, Bernstein ID. Density of the Notch ligand Delta1 determines generation of B and T cell precursors from hematopoietic stem cells. J Exp Med. 2005;201:1361–1366
  47. Bash J, Zong WX, Banga S, et al. Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors. EMBO J. 1999;18:2803–2811
  48. Ando K, Kanazawa S, Tetsuka T, et al. Induction of Notch signaling by tumor necrosis factor in rheumatoid synovial fibroblasts. Oncogene. 2003;22:7796–7803
  49. Ohishi K, Katayama N, Shiku H, Varnum-Finney B, Bernstein ID. Notch signalling in hematopoiesis. Semin Cell Dev Biol. 2003;14:143–150
  50. Ohishi K, Varnum-Finney B, Bernstein ID. Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells. J Clin Invest. 2002;110:1165–1174
  51. Varnum-Finney B, Wu L, Yu M, et al. Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling. J Cell Sci. 2000;113 Pt 23:4313–4318
  52. Stier S, Cheng T, Dombkowski D, Carlesso N, Scadden DT. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood. 2002;99:2369–2378
  53. Mancini SJ, Mantei N, Dumortier A, Suter U, Macdonald HR, Radtke F. Jagged1 dependent Notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation. Blood. 2005;105:2340–2342
  54. Saito T, Chiba S, Ichikawa M, et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity. 2003;18:675–685
  55. Fung E, Tang SM, Canner JP, et al. Delta-like 4 induces notch signaling in macrophages: implications for inflammation. Circulation. 2007;115:2948–2956
  56. Duarte A, Hirashima M, Benedito R, et al. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 2004;18:2474–2478

PII: S0301-472X(07)00728-X

doi: 10.1016/j.exphem.2007.12.012

Experimental Hematology
Volume 36, Issue 5 , Pages 545-558.e1 , May 2008